CHA News Article

CDC Issues Health Advisory for Acute Hepatitis and Liver Failure
Patients using dietary supplement at risk

The Centers for Disease Control and Prevention (CDC) recently issued a health advisory recommending vigilance by public health agencies, emergency departments and health care providers with patients who develop acute hepatitis or liver failure following the use of OxyELITE Pro, a weight loss and muscle-building nutritional supplement. The initial seven cases were reported by the Hawaii Department of Health. National case-finding efforts have identified several individuals from states outside Hawaii with reported OxyELITE Pro or other weight loss or muscle building dietary supplement use prior to the development of acute hepatitis of unknown cause. CDC, in collaboration with state health departments, is collecting additional clinical and epidemiologic information from these individuals to determine if the outbreak is national in scope. A summary, background, case definition, recommendations and more information can be found at the CDC’s Health Alert Network.